Clinical Trial Update: Radiotherapy Omitting Prophylactic Neck Irradiation With Neoadjuvant and Adjuvant Toripalimab in Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A phase 2 study is evaluating whether prophylactic neck irradiation can be omitted in nasopharyngeal carcinoma when toripalimab is given in neoadjuvant and adju…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Cancinoma (NPC) | Phase 2 | Status: NOT_YET_RECRUITING